Recommendations for non-medical paediatric biosimilar switching | |
- Adequate biosimilar teaching for all staff - A coherent message from all members of the team (medical, nursing, pharmacy, others) - Written and verbal patient education prior to switching - Disease and medication specific information to be provided to families - Honest and balanced yet positive framing of information - Detailed information on practical aspects of the biosimilar including device types, additives (including preservatives) and delivery logistics - Information to be written and endorsed by familiar treating team members rather than anonymous administrators/pharmacy |